Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas

Anticancer Research

Volumn 31, Issue 9, 2011, Pages 2963-2970

  Szczuraszek, Katarzyna ^a   Halon, Agnieszka ^a   Materna, Verena ^b   Mazur, Grzegorz ^a   Wrobel, Tomasz ^a   Kuliczkowski, Kazimierz ^a   Donizy, Piotr ^a   Holm, Per S ^c   Lage, Hermann ^b   Surowiak, Pawel ^a,d  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Charité Campus Benjamin Franklin Medical Center   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

Author keywords

Immunohistochemistry; Non Hodgkin's lymphoma; Prognosis; YB 1

Indexed keywords

Y BOX BINDING PROTEIN 1;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; Y-BOX-BINDING PROTEIN 1;

EID: 80051634115     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aisenberg AS: Coherent view of non-Hodgkin's lymphoma. J Clin Oncol 13: 2656-2664, 1995.
2. Müller AMS, Ihorst G, Mertelsmann R and Engelhardt M: Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84: 1-12, 2005. (Pubitemid 39625035)
3. Anderson JR, Armitage JO and Weisenburger DD: Epidemiology of the non-Hodgkin's Lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Project. Ann Oncol 9: 717-723, 1998.
4. Shipp MA, Harrington DP, Anderson JR and Armitage JO: A predictive model for aggressive non-Hodgkin's lymphoma. New Engl J Med 329: 987-993, 1993.
5. Kohno K, Izumi H, Uchiumi T, Ashizuka M and Kuwano M: The pleiotropic functions of the Y-box-binding protein, YB-1. BioEssays 25: 691-698, 2003.
6. Wolffe AP: Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. BioEssays 16: 245-251, 1994.
7. Tafuri SR and Wolffe AP: DNA binding, multimerization, and transcription stimulation by the Xenopus Y-box proteins in vitro. New Biologist 4: 349-359, 1992.
8. Lage H, Surowiak P and Holm PS: YB-1 as a potential target in cancer therapy. Pathologe 29: 187-190, 2008.
9. Swamynathan SK, Nambiar A and Guntaka RV: Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J 12: 515-522, 1998. (Pubitemid 28183510)
10. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer KJ, Dietel M, Dörken B and Royer HD: Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancer are associated with intrinsic MDR1 gene expression. Nat Med 5: 447-450, 1997. (Pubitemid 27145688)
11. Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, Jürchott K, Schmitt M and Royer HD: Y-box factor YB-1 predict drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer 97: 278-282, 2002. (Pubitemid 34049016)
12. Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K, Tsuneyoshi M, Kuwano M and Iwamoto Y: Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res 9: 2273-2277, 1998.
13. Saji H, Toi M, Saji S, Koike M, Kohno K and Kuwano M: Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma. Cancer Lett 190: 191-197, 2003. (Pubitemid 36136018)
14. Shibao K, Takano H, Nakayama Y, Okazaki K, Nagata N, Izumi H, Uchiumi T, Kuwano M, Kohno K and Itoh H: Enhanced coexpression of YB-1 and DNA topoizomerase II α genes in human colorectal carcinomas. Int J Cancer 83: 732-737, 1999.
15. Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H, Mitsumoto M, Kohno K, Kuwano M and Nakano H: Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 85: 2450-2454, 1999.
16. Skarin AT and Dorfman DM: Non-Hodgkin's lymphomas: current classification and management. CA-Cancer J Clin 47: 351-372, 1997. (Pubitemid 27494155)
17. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
18. Mantwill K, Köhler-Vargas N, Bernshausen A, Bieler A, Lage H, Kaszubiak A, Surowiak P, Dravits T, Treiber U, Hartung R, Gansbacher B and Holm PS: Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents. Cancer Res 66: 7195-7202, 2006. (Pubitemid 44197698)
19. Shibahara K, Sugio K, Osaki T, Uchiumi T, Maehara Y, Kohno K, Yasumoto K, Sugimachi K and Kuwano M: Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 7: 3151-3155, 2001. (Pubitemid 32963838)
20. Dahl E, En-Nia A, Wiesmann F, Krings R, Djudjaj S, Breuer E, Fuchs T, Wild PJ, Hartmann A, Dunn SE and Mertens PR: Nuclear detection of Y-box protein-I (YB-I) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer 9: 410, 2009.
21. Yang JY, Ha S, Yang Y and Kim JW: P-glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance. BMC Cancer 10: 388, 2010.
22. Lovett DH, Cheng S, Cape L, Pollock AS and Mertens PR: YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis. Biochem Biophys Res Commun 398: 482-488, 2010.
23. Yu YN, Yip GW, Tan PH, Thike AA, Matsumoto K, Tsujimoto M and Bay BH: Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol 37: 483-492, 2010.
24. Evdokimova V, Tognon C, Ng T and Sorensen PH: Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1. Cell Cycle 8: 2901-2906, 2009.
25. Del Valle L, Azizi SA, Krynska B, Enam S, Croul SE and Khalili K: Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiform. Ann Neurol 48: 932-936, 2000.
26. Holm PS, Lage H, Bergmann S, Jürchott K, Glockzin G, Bernshausen A, Mantwill K, Landhoff A, Wiehert A, Mymryk JS, Ritter T, Dietel M, Gänsbacher B and Royer HD: Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy. Cancer Res 64: 322-328, 2004.
27. Xu W, Zhou L, Qin R, Tang H and Shen H: Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome. Eur J Haematol 83: 313-319, 2009.
28. Kaszubiak A, Kupstat A, Müller U, Hausmann R, Holm PS and Lage H: Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1. Biochem Biophys Res Commun 357: 295-301, 2007. (Pubitemid 46584653)
29. Oda Y, Ohishi Y, Saito T, Hinoshita E, Uchiumi T, Kinukawa N, Iwamoto Y, Kohno K, Kuwano M and Tsuneyoshi M: Nuclear expression of Y-box-binding protein-I correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma. J Pathol 199: 251-258, 2003. (Pubitemid 36176032)
30. Kauffmann HM, Vorderstemann B and Schrenk D: Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites. Toxicol 167: 25-35, 2001. (Pubitemid 32830944)
31. Mertens PR, Harendza S, Pollock AS and Lovett DH: Glomerular mesangial cell-specific transactivation of matrx metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 272: 22905-22912, 1997. (Pubitemid 27386113)
32. Stein U, Jürchott K, Walther W, Bergmann S, Schlag PM and Royer HD: Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J Biol Chem 276: 28562-28569, 2001.
33. Wachowiak R, Thieltges S, Rawnaq T, Kaifi JT, Fiegel H, Metzger R, Quaas A, Mertens PR, Till H and Izbicki JR: Y-Box-binding protein-1 is a potential novel tumour marker for neuroblastoma. Anticancer Res 30: 1239-1242, 2010.
34. Holm PS, Bergmmann S, Jürchott K, Lage H, Brand K, Ladhoff A, Mantwill K, Curiel DT, Dobbelstein M, Dietel M, Gansbacher B and Royer HD: YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter. J Biol Chem 277: 10427-10434, 2002. (Pubitemid 34968163)
35. Koike K, Uchiumi T, Ohga T, Toh S, Wada M, Kohno K and Kuwano M: Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett 417: 390-394, 1997. (Pubitemid 27511629)